Johan Wedell-Wedellsborg

Insider Reports History

Entity
Individual
Location
Rungsted Strandvej 113, Rungsted Kyst, Denmark
Signature
/s/ John LaRocca, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Johan Wedell-Wedellsborg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Y-mAbs Therapeutics, Inc. Director, 10%+ Owner Common Stock 4.56M $54.7M $12.00 Jun 11, 2024 By WG Biotech ApS
Y-mAbs Therapeutics, Inc. Director, 10%+ Owner Common Stock 5.83K $69.9K $12.00 Jun 11, 2024 Direct
Y-mAbs Therapeutics, Inc. Director, 10%+ Owner Employee Stock Option (right to buy) 14.5K Jun 11, 2024 Direct

Insider Reports Filed by Johan Wedell-Wedellsborg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
YMAB Y-mAbs Therapeutics, Inc. Jun 11, 2024 2 $0 4 Jun 13, 2024 Director, 10%+ Owner
YMAB Y-mAbs Therapeutics, Inc. Dec 11, 2023 1 $44.2K 4 Dec 12, 2023 Director
YMAB Y-mAbs Therapeutics, Inc. Dec 7, 2023 3 $890K 4 Dec 11, 2023 Director
YMAB Y-mAbs Therapeutics, Inc. Nov 29, 2023 1 $309K 4 Dec 1, 2023 Director
YMAB Y-mAbs Therapeutics, Inc. Nov 27, 2023 2 $521K 4 Nov 29, 2023 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 8, 2023 2 $0 4 Jun 9, 2023 Director
YMAB Y-mAbs Therapeutics, Inc. May 15, 2023 1 $981K 4 May 17, 2023 Director
YMAB Y-mAbs Therapeutics, Inc. Jul 15, 2022 1 $0 4 Jul 19, 2022 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 10, 2021 1 -$406K 4 Jun 11, 2021 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 8, 2021 2 -$5.4M 4 Jun 10, 2021 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 7, 2021 1 -$2.47M 4 Jun 9, 2021 Director
YMAB Y-mAbs Therapeutics, Inc. Jun 3, 2021 2 -$1.15M 4 Jun 7, 2021 Director
YMAB Y-mAbs Therapeutics, Inc. May 28, 2021 2 -$1.15M 4 Jun 2, 2021 Director